TABLE OF CONTENTS
1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF THE NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET 12
1.4 LIMITATIONS 14
1.5 MARKETS COVERED 14
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 CURRENCY AND PRICING 20
2.5 DBMR TRIPOD DATA VALIDATION MODEL 21
2.6 MULTIVARIANT MODELLING 24
2.7 PRODUCT TYPE LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 VENDOR SHARE ANALYSIS 27
2.11 MARKET END USER COVERAGE GRID 28
2.12 SECONDARY SOURCES 29
2.13 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 32
4.1 PESTEL ANALYSIS 33
4.2 PORTER'S FIVE FORCES MODEL 34
5 REGULATIONS 35
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 40
6.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS 41
6.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS 42
6.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES 43
6.2 RESTRAINTS 44
6.2.1 HIGH COST OF PROCEDURES 44
6.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 45
6.3 OPPORTUNITIES 45
6.3.1 BELIEF AND TREND OF AUTOLOGOUS FAT GRAFTING IN YOUNG ADULTS 45
6.3.2 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES 47
6.4 CHALLENGES 48
6.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO 48
6.4.2 LACK OF SKILLED PERSONNEL 48
7 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY PRODUCT TYPE 49
7.1 OVERVIEW 50
7.2 LIPOSUCTION SYSTEMS 51
7.3 ASPIRATION AND HARVESTING SYSTEMS 52
7.4 FAT PROCESSING SYSTEMS 52
7.5 INTEGRATED FAT TRANSFER SYSTEMS 53
7.6 DE-EPITHELIALIZATION DEVICES 53
7.7 ACCESSORIES 54
8 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY APPLICATION 55
8.1 OVERVIEW 56
8.2 BREAST AUGMENTATION 57
8.3 BUTTOCK AUGMENTATION 58
8.4 FACIAL FAT GRAFTING 58
8.5 HAND REJUVENATION 59
8.6 OTHERS 59
9 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY GENDER 60
9.1 OVERVIEW 61
9.2 FEMALE 62
9.3 MALE 63
10 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY AGE GROUP 64
10.1 OVERVIEW 65
10.2 41-50 66
10.3 20-40 67
10.4 ABOVE 50 67
11 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY END USER 68
11.1 OVERVIEW 69
11.2 HOSPITALS 70
11.3 PLASTIC SURGERY CENTERS 71
11.4 ON-SITE CLINICS 71
11.5 OTHERS 71
12 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY DISTRIBUTION CHANNEL 73
12.1 OVERVIEW 74
12.2 DIRECT TENDER 75
12.3 RETAIL SALES 76
13 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET, BY REGION 77
13.1 NORTH AMERICA 78
13.1.1 U.S. 78
13.1.2 CANADA 78
13.1.3 MEXICO 78
14 NORTH AMERICA AUTOLOGOUS FAT GRAFTING MARKET: COMPANY LANDSCAPE 79
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 79
15 COMPANY PROFILES 80
15.1 ABBVIE INC. 80
15.1.1 COMPANY SNAPSHOT 80
15.1.2 REVENUE ANALYSIS 80
15.1.3 COMPANY SHARE ANALYSIS 81
15.1.4 PRODUCT PORTFOLIO 81
15.1.5 RECENT DEVELOPMENTS 81
15.2 CYNOSURE 82
15.2.1 COMPANY SNAPSHOT 82
15.2.2 COMPANY SHARE ANALYSIS 82
15.2.3 PRODUCT PORTFOLIO 82
15.2.4 RECENT DEVELOPMENT 82
15.3 SOLTA MEDICAL 83
15.3.1 COMPANY SNAPSHOT 83
15.3.2 COMPANY SHARE ANALYSIS 83
15.3.3 PRODUCT PORTFOLIO 83
15.3.4 RECENT DEVELOPMENT 83
15.4 ALMA LASERS 84
15.4.1 COMPANY SNAPSHOT 84
15.4.2 COMPANY SHARE ANALYSIS 84
15.4.3 PRODUCT PORTFOLIO 85
15.4.4 RECENT DEVELOPMENT 85
15.5 MENTOR WORLDWIDE LLC 86
15.5.1 COMPANY SNAPSHOT 86
15.5.2 COMPANY SHARE ANALYSIS 86
15.5.3 PRODUCT PORTFOLIO 86
15.5.4 RECENT DEVELOPMENT 86
15.6 ASPIRE MEDICAL INNOVATION 87
15.6.1 COMPANY SNAPSHOT 87
15.6.2 PRODUCT PORTFOLIO 87
15.6.3 RECENT DEVELOPMENT 87
15.7 BIMINI HEALTH TECH 88
15.7.1 COMPANY SNAPSHOT 88
15.7.2 PRODUCT PORTFOLIO 88
15.7.3 RECENT DEVELOPMENTS 88
15.8 BLACK & BLACK SURGICAL 89
15.8.1 COMPANY SNAPSHOT 89
15.8.2 PRODUCT PORTFOLIO 89
15.8.3 RECENT DEVELOPMENT 89
15.9 GENESIS BIOSYSTEMS 90
15.9.1 COMPANY SNAPSHOT 90
15.9.2 PRODUCT PORTFOLIO 90
15.9.3 RECENT DEVELOPMENT 90
15.10 GREY MEDICAL 91
15.10.1 COMPANY SNAPSHOT 91
15.10.2 PRODUCT PORTFOLIO 91
15.10.3 RECENT DEVELOPMENT 91
15.11 HK SURGICAL INC. 92
15.11.1 COMPANY SNAPSHOT 92
15.11.2 PRODUCT PORTFOLIO 92
15.11.3 RECENT DEVELOPMENT 92
15.12 HUMAN MED AG 93
15.12.1 COMPANY SNAPSHOT 93
15.12.2 PRODUCT PORTFOLIO 93
15.12.3 RECENT DEVELOPMENT 93
15.13 LIPOGEMS INTERNATIONAL S.P.A. 94
15.13.1 COMPANY SNAPSHOT 94
15.13.2 PRODUCT PORTFOLIO 94
15.13.3 RECENT DEVELOPMENT 94
15.14 MEDICON EG 95
15.14.1 COMPANY SNAPSHOT 95
15.14.2 PRODUCT PORTFOLIO 95
15.14.3 RECENT DEVELOPMENT 95
15.15 MICROAIRE SURGICAL INSTRUMENTS, LLC 96
15.15.1 COMPANY SNAPSHOT 96
15.15.2 PRODUCT PORTFOLIO 96
15.15.3 RECENT DEVELOPMENT 96
15.16 MOLLER MEDICAL GMBH 97
15.16.1 COMPANY SNAPSHOT 97
15.16.2 PRODUCT PORTFOLIO 97
15.16.3 RECENT DEVELOPMENT 97
15.17 MTF BIOLOGICS 98
15.17.1 COMPANY SNAPSHOT 98
15.17.2 PRODUCT PORTFOLIO 98
15.17.3 RECENT DEVELOPMENT 98
15.18 STERIMEDIX LIMITED 99
15.18.1 COMPANY SNAPSHOT 99
15.18.2 PRODUCT PORTFOLIO 99
15.18.3 RECENT DEVELOPMENT 99
15.19 TULIP AESTHETICS 100
15.19.1 COMPANY SNAPSHOT 100
15.19.2 PRODUCT PORTFOLIO 100
15.19.3 RECENT DEVELOPMENT 100
16 QUESTIONNAIRE 101
17 RELATED REPORTS 104

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.